{Reference Type}: Journal Article
{Title}: dMAD7 is a promising tool for targeted gene regulation in the methylotrophic yeast Komagataella phaffii.
{Author}: Krappinger JC;Aguilar Gomez CM;Hoenikl A;Schusterbauer V;Hatzl AM;Feichtinger J;Glieder A;
{Journal}: N Biotechnol
{Volume}: 83
{Issue}: 0
{Year}: 2024 Jul 2
{Factor}: 6.49
{DOI}: 10.1016/j.nbt.2024.06.008
{Abstract}: The methylotrophic yeast Komagataella phaffii is a popular host system for the pharmaceutical and biotechnological production of recombinant proteins. CRISPR-Cas9 and its derivative CRISPR interference (CRISPRi) offer a promising avenue to further enhance and exploit the full capabilities of this host. MAD7 and its catalytically inactive variant "dead" MAD7 (dMAD7) represent an interesting alternative to established CRISPR-Cas9 systems and are free to use for industrial and academic research. CRISPRi utilizing dMAD7 does not introduce double-strand breaks but only binds to the DNA to regulate gene expression. Here, we report the first use of dMAD7 in K. phaffii to regulate the expression of the enhanced green fluorescent protein (eGFP). A reduction of eGFP fluorescence level (up to 88 %) was achieved in random integration experiments using dMAD7 plasmids. Integration loci/events of investigated strains were assessed through whole genome sequencing. Additionally, RNA-sequencing experiments corroborated the whole genome sequencing results and showed a significantly reduced expression of eGFP in strains containing a dMAD7 plasmid, among others. Our findings conclusively demonstrate the utility of dMAD7 in K. phaffii through successfully regulating eGFP expression.